stock recommendations: Hot Stocks: Brokerage views on Nykaa, Metropolis Healthcare, Gujarat Gas, Medanta and Zee Entertainment

Global brokerage firm Goldman Sachs maintained its neutral stance on , Goldman Sachs also has a neutral rating on , Jefferies maintained underperform rating on while it has a buy rating on Medanta, and Citigroup maintained a buy on Zee Entertainment.

We have collated a list of recommendations from top brokerage firms from ETNow and other sources:

Goldman Sachs on Nykaa: Neutral| Target Rs 200
Goldman Sachs maintained its neutral rating on Nykaa with a target price of Rs 200. The company missed Q3 estimates, and there is no clear signs of a near-term pick-up in the beauty and personal care (BPC) growth.

The global investment bank cuts revenue estimates by 4% and EBTIDA estimates by 14%-28% over FY23-25.

Goldman Sachs on Metropolis Healthcare: Neutral| Target Rs 1400
Goldman Sachs maintained its neutral rating on Metropolis Healthcare with a target price of Rs 1400. The December quarter results were below estimates.

Full business normalization is still a few quarters away. The global investment bank slashed FY23-25E EPS estimates by 7% to factor in a relatively slower topline growth and management commentary on the call.

Jefferies on Gujarat Gas: Underperform| Target Rs 405
Jefferies maintained an underperform rating on Gujarat Gas with a target price of Rs 405. The Q3 results were ahead on better margins while overall volume growth was in line with estimates.

Propane economics turn favorable, and the management expects a strong volume recovery in Morbi. Regulatory tailwinds provide a margin cushion in CNG.

Jefferies on Medanta: Buy| Target Rs 550
Jefferies maintained a buy rating on Medanta with a target price of Rs 550. The company debuted with a strong beat compared to estimates.

Average Revenue per Occupied Bed (ARPOB) during the quarter was +4% on a YoY basis while occupancy was at 59%.

Citi on Zee Entertainment: Buy| Target Rs 280
Citigroup maintained its buy rating on Zee Entertainment with a target price of Rs 280. The muted performance continued in Q3.

The global investment bank slashed FY23 earnings estimates by 35% due to near-term market uncertainties.

FY24-25E earnings reduction is lower at 11-15%. The Ad-revenue market remains under pressure in the near term, said the note.

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)